Home -> Law Blog Directory -> Corporate & Securities Law Blogs -> Antitrust Commentary
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Corporate & Securities Law
: Antitrust CommentarySham Litigation Allegations Held Sufficient to Avoid Dismissal under Noerr-Pennington Doctrine
By Matthew S. Wild
As examined in the February 17, 2009 Post, there have been a number of recent appeallte decisions reviewing successful Noerr-Pennington immunity defense assertions. Alternative Electrodes, LLC v. EPMI, Inc., No. 08-CV-1247 (JFB)(ETB), 2009 WL 250474 (E.D.N.Y. Feb. 4, 2009), provides a recent illustration of the allegations necessary to defeat that defense.
In that case, plaintiff, a medical device manufacturer, claims that its competitor filed sham patent litigation against it and other competitors and made false statements about the patent litigation to plaintiff?s customers to allow it to monopolize (or gain a dangerous probability of monopolizing) the market for electrical muscle stimulation devices used to treat difficulty swallowing. Plaintiff alleged, among other things, ?from the beginning of the patent litigation that the primary, if not sole purpose, of instigating suit was to advise customers of the pending (but meritless) litigation and attempt to drive [plaintiff] from the market. The litigation was objectively unreasonable and was initiated in order to interfere directly with [plaintiff?s] business relationships and activities. … The sham patent suit strategy failed. Recognizing the frivolity of the claim in light of prior art, these Defendants completely dismissed their suit … without any penalty or payment of any kind.? Id. at *7. The Court held that ?such allegations are sufficient to withstand a motion to dismiss? based on the Noerr-Pennington immunity defense because ?Plaintiff alleges that the litigation was both subjectively and objectively baseless and plausibly supports this claim with the assertion that there could be no valid patent claim due to the existence of ?prior art.?? Id.
Full post as published by Antitrust Commentary on March 08, 2009 (boomark / email).
Mesothelioma Law Suit
Asbestos Exposure
$189 Million Settlement Reached in Slab Litigation
$189 Million Settlement Reached in Slab Litigation
Breakthrough Settlement Reached In Chinese Drywall Litigation
Chinese Drywall Litigation Breakthrough Settlement Reached
CVS Mailing
Sparks Allegations of Privacy Violation
Overtime for Programmers
alleging that some companies try to avoid paying employees overtime by categorizing them as "salaried" employees.
Evergreen
Wachovia, Settle Securities Allegations over Ultra Short Opportunities Fund
Lawsuit Filed Against Legacy Health Care Facilities for Nursing Home Abuse
Legacy Health Care Facilities Face Class Action Over Allegations of Abuse

Kaiser v. Abbott Labs (9th Cir. - Jan. 13, 2009)
FDA Citizen Petition Found To Be Objectively Baseless
Sue L. Robinson: Noerr-Pennington Immunity Applies to Suits Brought on "Weak" Patents
The Future of the "Group Pleading Doctrine"
"Citizen Petition" To FDA Raised Genuine Issues On Sham Exception To Noerr-Pennington Doctrine








